Kingsley Advani
Angel Investor
San Francisco, United States
Kingsley Advani (born October 24, 1993, in London, United Kingdom) is a British tech entrepreneur, investor, and author based in Dubai, United Arab Emirates. He is the Founder and CEO of Allo, an exchange for tokenized stocks managing over $2 billion in tokenized real-world assets, and the founder of Allocations, a fintech platform that has grownto administer more than $2 billion in assets across 30,000+ high-net-worth clients.Advani began his entrepreneurial journey at the age of 13, launching a digital commerce business on eBay, before discovering Bitcoin in 2011 while studying finance and economics. In 2013, he allocated his IBM internship savings into Bitcoin and other emerging cryptocurrencies, becoming an early investor in what later became a multi-billion-dollar asset class. By his mid-twenties, he had invested in more than 200 companies, including unicorns such as SpaceX, Solana, Coinbase, Robinhood, and eToro.In 2017, he co-founded a global investor syndicate that collectively managed more than $4 billion in assets. Two years later, he launched Allocations, a platform providing infrastructure for fund administration, SPVs, and private market investments. CNBC recognized him as the “Blockchain Oracle” for his early insights into cryptocurrency adoption and market trends.Through his ventures, Advani has become a leading voice in fintech, blockchain, tokenization, private markets, and Web3, with frequent speaking engagements at global conferences including the SF Blockchain Summit, Beyond Blocks, Coinfest Asia, and the Ritossa Summit in Dubai. His commentary emphasizes how blockchain and emerging technologies can democratize access to alternative assets and reduce the barriers to launching micro-funds.Advani is also the author of The Blockchain Oracle: How Technology, Finance, and Vision Shape the Future of Global Investing (2025), a book that explores the intersection of blockchain, fintech, and global finance.
- Total investments:
- 47
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Kingsley Advani invests in
Stages Kingsley Advani invests in
Countries Kingsley Advani invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $120k–$8.3M
- Pre-Seed
- $120k–$4.5M
- Series A
- $4M–$183M
Investment Focus
Industry
- FinTech 11 (23%)
- Financial Services 9 (19%)
- Biotechnology 8 (17%)
- Aerospace 7 (15%)
- Blockchain 7 (15%)
Stage
- Seed 20 (43%)
- Pre-Seed 6 (13%)
- Series A 5 (11%)
- Series B 3 (6%)
- Series C 2 (4%)
Country
- United States 30 (64%)
- Singapore 2 (4%)
- United Kingdom 2 (4%)
- China 1 (2%)
- Canada 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Allocations is a technology company building a private equity & venture capital economy that is open to all, enabling more financial inclusion for every person and business. Allocations has raised in excess of $7m from over 200 investors as of August 2021 including Irish Angels, Vitalize VC, Allocations Angels, LFG Ventures, Browder Capital,TVC, Jamie Rogozinski, Joey Krug, Bruce Menin and Russell Galbut. To date Allocations has powered over 300 private funds, totaling approximately $250m in volume. | $4M / Series A / Aug 05, 2021 | ||
| CheckStep provides a AI-powered Trust & Safety and UGC management software to online platform worldwide. It enables company to manage the full policy management life-cycle. | $430K / Pre-Seed / Jun 28, 2021 | ||
| Allocations is a technology company building a private equity & venture capital economy that is open to all, enabling more financial inclusion for every person and business. Allocations has raised in excess of $7m from over 200 investors as of August 2021 including Irish Angels, Vitalize VC, Allocations Angels, LFG Ventures, Browder Capital,TVC, Jamie Rogozinski, Joey Krug, Bruce Menin and Russell Galbut. To date Allocations has powered over 300 private funds, totaling approximately $250m in volume. | $1M / Seed / Aug 31, 2020 | ||
| Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology. | $22M / Convertible Note / May 31, 2020 | ||
| OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more preciseintervention for this complex and devastating disease. | $4.5M / Pre-Seed / Apr 01, 2020 | ||
| New Age Meats is a biotechnology company that develops healthy cultivated meat grown from animal cells instead of animal slaughter. | $2.7M / Seed / Jan 09, 2020 | ||
| Volumetric is an advanced biomaterials and biofabrication company that develops a 3D bioprinting platform intended to create materials with living cells with applications in biomaterials, cancer research, and human organ replacements. | $1.8M / Seed / Nov 19, 2019 | ||
| Orbit Fab offers a supply of satellite propellant in Earth Orbit that expands the operational potential of new and existing space assets. It develops the infrastructure needed to grow a thriving in-space market for products and services that support both existing space businesses (communications and Earth observation) and new industries like spacetourism, manufacturing, and mining. The future for satellites is no longer restricted to the fuel they are launched with. Orbit Fab was founded in 2018 by its Co-Founders Daniel Faber and Jeremy Schiel. | $3.3M / Seed / Oct 04, 2019 | ||
| Relativity Space is an aerospace company that designs, develops, and builds 3D-printed rockets. a vertically integrated technology platform, Relativity is at the forefront of an inevitable shift toward software-defined manufacturing by fusing 3D printing, artificial intelligence, and autonomous robotics. It offers a radically simplified supplychain, building a rocket with 100x fewer parts in less than 60 days. Relativity Space is backed by leading investors including Bond, Tribe Capital, Playground Global, Y Combinator, Social Capital, and Mark Cuban. | $140M / Series C / Oct 01, 2019 | ||
| Juvenescence Limited is a British Virgin Islands-based holding company that invests in human aging and longevity. Juvenescence has raised $111M to build an ecosystem and pipeline of assets targeting aging, age-related disease, and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development oftherapeutics that meaningfully extend human healthspan and eventually lifespan. A meaningful increase in lifespan in the already aging world will have profound implications on all sectors of society, and in particular healthcare, education, insurance, and leisure.The company creates and partners with new companies with longevity-related therapeutics, by in-licensing compounds from academia and industry, or forming joint ventures with the foremost longevity scientists and leading research institutions. Their work is based on a novel scientific understanding of the underlying biological causes of aging, to create evidence-based therapeutics that can treat diseases of aging.Juvenescence's goal is to extend both lifespan and healthspan, by developing therapeutics that slow aging and promote juvenescence. | $100M / Series B / Aug 19, 2019 | ||
| See all 47 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Kingsley Advani invest in?
Kingsley Advani invests primarily in FinTech, Financial Services and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 47 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Kingsley Advani's check size?
Kingsley Advani typically joins rounds of $120k–$8.3M at Seed, $120k–$4.5M at Pre-Seed and $4M–$183M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kingsley Advani participates in.
How do I contact Kingsley Advani?
Public channels for Kingsley Advani include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kingsley Advani last invest?
The most recent investment recorded for Kingsley Advani closed in Aug 2021. Shizune tracks 47 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
